Vespole, Rachel

Vespole, Rachel was paid $29K by Medicaid between Jul 2018 and Mar 2023, across 10 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.

33Billing provider infoVESPOLE, RACHEL
HOLLISTON, MA 01746

33aNPI1992804207assigned 09/22/2006

33bProvider typePediatrics Physician

28Total paid$29K

24GClaims787

24DCodes billed10

24AFirst – last monthJul 2018 – Mar 2023

Compared with peers

Next to other Pediatrics Physician providers in Massachusetts

Rank by total paid#594 of 1,273

Median peer was paid$24K

This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	122	$4K
2019	85	$3K
2020	108	$2K
2021	108	$2K
2022	282	$14K
2023	82	$4K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	38%	109	104	$11K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	17%	86	86	$5K
90460	Immunization administration through 18 years of age via any route, first or only component	14%	139	122	$4K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	8.4%	271	270	$2K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	7.0%	78	77	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	6.9%	14	14	$2K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	5.7%	12	12	$2K
96127		1.7%	48	48	$492.96
99051		<1%	13	13	$215.28
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	17	16	$174.59

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.